Scarica l'app Stockscreener
18.62
3.44%
0.62
Dopo l'orario di chiusura:
18.52
-0.10
-0.54%
Precedente Chiudi:
$18.00
Aprire:
$18.01
Volume 24 ore:
1.18M
Relative Volume:
0.74
Capitalizzazione di mercato:
$1.06B
Reddito:
$322.02M
Utile/perdita netta:
$-102.47M
Rapporto P/E:
-10.18
EPS:
-1.8295
Flusso di cassa netto:
$-80.57M
1 W Prestazione:
+11.56%
1M Prestazione:
-17.54%
6M Prestazione:
-35.70%
1 anno Prestazione:
-61.62%
Intervallo 1D:
$17.71
$18.67
Intervallo di 1 settimana:
$16.86
$18.67
Portata 52W:
$16.66
$51.18
Procept Biorobotics Corp Stock (PRCT) Company Profile
Nome
Procept Biorobotics Corp
Settore
Industria
Telefono
(650) 232-9832
Indirizzo
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
18.62 | 1.01B | 322.02M | -102.47M | -80.57M | -1.8295 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-06 | Iniziato | Robert W. Baird | Neutral |
| 2026-02-26 | Downgrade | BofA Securities | Neutral → Underperform |
| 2026-02-26 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-12-12 | Iniziato | UBS | Buy |
| 2025-12-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-09-02 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-07-09 | Iniziato | Stephens | Overweight |
| 2025-07-07 | Iniziato | Oppenheimer | Perform |
| 2024-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-14 | Iniziato | Jefferies | Hold |
| 2023-08-11 | Iniziato | Piper Sandler | Overweight |
| 2023-05-31 | Iniziato | William Blair | Outperform |
| 2022-10-31 | Iniziato | BTIG Research | Neutral |
| 2022-10-25 | Iniziato | Truist | Buy |
| 2022-09-02 | Iniziato | Wells Fargo | Overweight |
| 2022-07-15 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Iniziato | B. Riley Securities | Buy |
| 2021-10-11 | Iniziato | BofA Securities | Buy |
| 2021-10-11 | Iniziato | Cowen | Outperform |
| 2021-10-11 | Iniziato | Goldman | Neutral |
| 2021-10-11 | Iniziato | Guggenheim | Buy |
| 2021-10-11 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Procept Biorobotics Corp Borsa (PRCT) Ultime notizie
UBS Downgrades PROCEPT BioRobotics to Neutral From Buy, Cuts Price Target to $20 From $30 - marketscreener.com
PROCEPT BIOROBOTICS CORPORATION (PRCT) INVESTOR ALERT Investors With Large Losses in PROCEPT BioRobotics Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights - Supply Chain Digital
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit - AOL.ca
PROCEPT BioRobotics Corporation Revenue Breakdown – BOATS:PRCT - TradingView
INVESTOR ALERT: Securities Class Action Filed Against PROCEPT BioRobotics Corporation – Investors Encouraged to Contact Kirby McInerney LLP - Business Wire
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - marketscreener.com
Law Offices of Howard G. Smith Encourages PROCEPT BioRobotics Corporation (PRCT) Shareholders To Inquire About Securities Fraud Class Action - WBOC TV
Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
Notice to Long-Term Shareholders of Cogent Communications - GlobeNewswire
Notice to Long-Term Shareholders of Cogent Communications Holdings, Inc. (NASDAQ: CCOI); EquipmentShare.com, Inc. (NASDAQ: EQPT); Photronics, Inc. (NASDAQ: PLAB); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.
Class action lawsuit filed against PROCEPT BioR... - Pluang
PROCEPT BIOROBOTICS CORPORATION (PRCT) INVESTOR ALERT - GlobeNewswire
Procept Biorobotics Corp (PRCT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Procept BioRobotics faces class action lawsuit over inflated sales and undisclosed inventory issues. - Pluang
PRCT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead the Procept Class Action Lawsuit - PR Newswire
INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Intuit Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Class action lawsuit alleges PROCEPT BioRobotics inflated revenue via aggressive discounting. - Pluang
Procept BioRobotics: Filling Robots Slower Than Placing Them (NASDAQ:PRCT) - Seeking Alpha
Procept Biorobotics Corp (PRCT) Cash Flow - TradingKey
PRCT|Procept Biorobotics Corp|Price:17.700|Chg%:+1.010 - TradingKey
PRCT|Procept Biorobotics Corp|Price:17.480| - TradingKey
Procept Biorobotics Corp (PRCT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Procept Biorobotics Corp (PRCT) Institutional Confidence - TradingKey
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with the Schall Law Firm - The Daily Tribune News
Procept Biorobotics Corp (PRCT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PRCT|Procept Biorobotics Corp|Price:17.250|Chg%:+0.560 - TradingKey
Procept Biorobotics Corp. (PRCT) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Procept Biorobotics Corp. (PRCT) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Procept Biorobotics Corp (PRCT) Income Statement - TradingKey
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action; Contact Robbins LLP for Information About Recovering Your Losses - The AI Journal
PRCT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files - GlobeNewswire
Procept Biorobotics Corp (PRCT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Procept Biorobotics stock hits 52-week low at $17.95 By Investing.com - Investing.com South Africa
Procept Biorobotics stock hits 52-week low at $17.95 - Investing.com
PROCEPT BioRobotics Corporation (PRCT): Investor Outlook on a Potential 52% Upside in the Healthcare Sector - DirectorsTalk Interviews
Analysts’ Opinions Are Mixed on These Healthcare Stocks: TG Therapeutics (TGTX), Protagonist Therapeutics (PTGX) and PROCEPT BioRobotics (PRCT) - The Globe and Mail
PROCEPT BioRobotics (PRCT) Gains On Coverage And Trial Progress, Is The Stock Still Cheap? - Sahm
Mobia Medical (MOBI) names ex-PROCEPT CEO Reza Zadno as director - Stock Titan
Procept Biorobotics Corp stock hits 52-week low at 19.2 USD - Investing.com Nigeria
PROCEPT BioRobotics to report Q2 2026 results on August 4 - scanx.trade
Procept Biorobotics Corp stock hits 52-week low at 19.2 USD By Investing.com - Investing.com South Africa
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026 - The Manila Times
PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 - Moomoo
PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20 - Stocktwits
Procept BioRobotics shares slide after Leerink downgrade cites rising competitive risks - MSN
Pooja Sharma Net Worth (2026) - GuruFocus
Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT) - The Globe and Mail
PROCEPT BioRobotics stock stays guided by procedure demand - AD HOC NEWS
Truist Downgrades PROCEPT BioRobotics to Hold From Buy, Lowers Price Target to $25 From $30 - marketscreener.com
PRCTProcept BioRobotics Corp Dividends - Finviz
Truist cuts Procept BioRobotics stock rating on reimbursement concerns By Investing.com - Investing.com Nigeria
Procept Biorobotics Corp Azioni (PRCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Procept Biorobotics Corp Azioni (PRCT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Waters Kevin | EVP, CFO |
Jun 08 '26 |
Sale |
28.48 |
357 |
10,167 |
151,201 |
| Templin Barry L | EVP, Chief Technology Officer |
Jun 08 '26 |
Sale |
28.48 |
358 |
10,195 |
68,953 |
1.04%
11.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):